Table of Contents Author Guidelines Submit a Manuscript
International Journal of Biomaterials
Volume 2017, Article ID 8074890, 9 pages
https://doi.org/10.1155/2017/8074890
Research Article

Application of Synthetic Polymeric Scaffolds in Breast Cancer 3D Tissue Cultures and Animal Tumor Models

Department of Biomedical Sciences, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA 99210, USA

Correspondence should be addressed to Weimin Li; ude.usw@il.nimiew

Received 23 October 2017; Accepted 22 November 2017; Published 17 December 2017

Academic Editor: Jie Deng

Copyright © 2017 Girdhari Rijal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Pampaloni, E. G. Reynaud, and E. H. K. Stelzer, “The third dimension bridges the gap between cell culture and live tissue,” Nature Reviews Molecular Cell Biology, vol. 8, no. 10, pp. 839–845, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. B. M. Baker and C. S. Chen, “Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues,” Journal of Cell Science, vol. 125, part 13, pp. 3015–3024, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Hickman, R. Graeser, R. de Hoogt et al., “Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo,” Biotechnology Journal, vol. 9, no. 9, pp. 1115–1128, 2014. View at Publisher · View at Google Scholar
  4. M. J. Bissell, A. Rizki, and I. S. Mian, “Tissue architecture: The ultimate regulator of breast epithelial function,” Current Opinion in Cell Biology, vol. 15, no. 6, pp. 753–762, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Mseka, J. R. Bamburg, and L. P. Cramer, “ADF/cofilin family proteins control formation of oriented actin-filament bundles in the cell body to trigger fibroblast polarization,” Journal of Cell Science, vol. 120, part 24, pp. 4332–4344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. G. D. Prestwich, “Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery,” Accounts of Chemical Research, vol. 41, no. 1, pp. 139–148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Rijal and W. Li, “3D scaffolds in breast cancer research,” Biomaterials, vol. 81, pp. 135–156, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. M. T. Santini, G. Rainaldi, R. Romano et al., “MG-63 human osteosarcoma cells grown in monolayer and as three-dimensional tumor spheroids present a different metabolic profile: a (1)H NMR study,” FEBS Letters, vol. 557, no. 1–3, pp. 148–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Cheema, R. A. Brown, B. Alp, and A. J. MacRobert, “Spatially defined oxygen gradients and vascular endothelial growth factor expression in an engineered 3D cell model,” Cellular and Molecular Life Sciences, vol. 65, no. 1, pp. 177–186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Valcarcel, B. Arteta, A. Jaureguibeitia et al., “Three-dimensional growth as multicellular spheroid activates the proangiogenic phenotype of colorectal carcinoma cells via LFA-1-dependent VEGF: implications on hepatic micrometastasis,” Journal of Translational Medicine, vol. 6, article 57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. P. A. Kenny, G. Y. Lee, C. A. Myers et al., “The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression,” Molecular Oncology, vol. 1, no. 1, pp. 84–96, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Fischbach, J. K. Hyun, S. X. Hsiong, M. B. Evangelista, W. Yuen, and D. J. Mooney, “Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 106, no. 2, pp. 399–404, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Smith, M. Wilson, J. H. Ward et al., “Recapitulation of Tumor Heterogeneity and Molecular Signatures in a 3D Brain Cancer Model with Decreased Sensitivity to Histone Deacetylase Inhibition,” PLoS ONE, vol. 7, no. 12, Article ID e52335, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. David, V. Dulong, D. Le Cerf, L. Cazin, M. Lamacz, and J.-P. Vannier, “Hyaluronan hydrogel: An appropriate three-dimensional model for evaluation of anticancer drug sensitivity,” Acta Biomaterialia, vol. 4, no. 2, pp. 256–263, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. L. Horning, S. K. Sahoo, S. Vijayaraghavalu et al., “3-D tumor model for in vitro evaluation of anticancer drugs,” Molecular Pharmaceutics, vol. 5, no. 5, pp. 849–862, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Rijal and W. Li, “A versatile 3D tissue matrix scaffold system for tumor modeling and drug screening,” Science Advances, vol. 3, no. 9, Article ID e1700764, 16 pages, 2017. View at Publisher · View at Google Scholar
  17. Y. Y. Brahatheeswaran, T. Maekawa, and D. S. Kumar, “Polymeric scaffolds in tissue engineering application: a review,” International Journal of Polymer Science, vol. 2011, Article ID 290602, pp. 1–19, 2011. View at Google Scholar
  18. M. S. Shoichet, “Polymer scaffolds for biomaterials applications,” Macromolecules , vol. 43, no. 2, pp. 581–591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Rijal, B. S. Kim, F. Pati, D.-H. Ha, S. W. Kim, and D.-W. Cho, “Robust tissue growth and angiogenesis in large-sized scaffold by reducing H2O2-mediated oxidative stress,” Biofabrication, vol. 9, no. 1, Article ID 015013, 2017. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Naz, Y. Cui, C. J. Collins, D. H. Thompson, and J. Irudayaraj, “PLGA-PEG nano-delivery system for epigenetic therapy,” Biomedicine & Pharmacotherapy, vol. 90, pp. 586–597, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Taghavi, M. Ramezani, M. Alibolandi, K. Abnous, and S. M. Taghdisi, “Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery,” Cancer Letters, vol. 400, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  22. Q. L. Loh and C. Choong, “Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size,” Tissue Engineering Part B: Reviews, vol. 19, no. 6, pp. 485–503, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. P. X. Ma and J.-W. Choi, “Biodegradable polymer scaffolds with well-defined interconnected spherical pore network,” Tissue Engineering Part A, vol. 7, no. 1, pp. 23–33, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Izquierdo, N. Garcia-Giralt, M. T. Rodriguez et al., “Biodegradable PCL scaffolds with an interconnected spherical pore network for tissue engineering,” Journal of Biomedical Materials Research Part A, vol. 85, no. 1, pp. 25–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Li, M. Petrimpol, K. D. Molle, M. N. Hall, E. J. Battegay, and R. Humar, “Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2,” Circulation Research, vol. 100, no. 1, pp. 79–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Weigelt, A. T. Lo, C. C. Park, J. W. Gray, and M. J. Bissell, “HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment,” Breast Cancer Research and Treatment, vol. 122, no. 1, pp. 35–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. N. Li, P. Cao, X. N. Zhang, S. X. Zhang, and Y. H. He, “In vitro degradation and cell attachment of a PLGA coated biodegradable Mg-6Zn based alloy,” Journal of Materials Science, vol. 45, no. 22, pp. 6038–6045, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. K. M. Hakkinen, J. S. Harunaga, A. D. Doyle, and K. M. Yamada, “Direct comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of fibroblasts in four different three-dimensional extracellular matrices,” Tissue Engineering Part A, vol. 17, no. 5-6, pp. 713–724, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Knight and S. Przyborski, “Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro,” Journal of Anatomy, vol. 227, no. 6, pp. 746–756, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. C. M. Taylor, B. Blanchard, and D. T. Zava, “Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen,” Cancer Research, vol. 44, no. 4, pp. 1409–1414, 1984. View at Google Scholar · View at Scopus
  31. V. Hongisto, S. Jernström, V. Fey et al., “High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells,” PLoS ONE, vol. 8, no. 10, Article ID e77232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. C. G. Knight, L. F. Morton, D. J. Onley et al., “Identification in collagen type I of an integrin α2β1-binding site containing an essential GER sequence,” The Journal of Biological Chemistry, vol. 273, no. 50, pp. 33287–33294, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Ding, X.-L. Fan, X. Xu et al., “Epigenetic silencing of ITGA2 by MiR-373 promotes cell migration in breast cancer,” PLoS ONE, vol. 10, no. 8, Article ID e0135128, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. G. P. H. Gui, J. R. Puddefoot, G. P. Vinson, C. A. Wells, and R. Carpenter, “In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix,” British Journal of Surgery, vol. 82, no. 9, pp. 1192–1196, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Lochter, M. Navre, Z. Werb, and M. J. Bissell, “α1 and α2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression,” Molecular Biology of the Cell, vol. 10, no. 2, pp. 271–282, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. M. M. Zutter, S. A. Santoro, W. D. Staatz, and Y. L. Tsung, “Re-expression of the α2β1 integrin abrogates the malignant phenotype of breast carcinoma cells,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 92, no. 16, pp. 7411–7415, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Cekanova and K. Rathore, “Animal models and therapeutic molecular targets of cancer: utility and limitations,” Drug Design, Development and Therapy, vol. 8, pp. 1911–1922, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. R. F. Song, X. J. Li, X. L. Cheng et al., “Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors,” Oncology Reports, vol. 32, no. 4, pp. 1481–1488, 2014. View at Publisher · View at Google Scholar
  39. H. Zhang, H. Hu, H. Zhang et al., “Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis,” Nanoscale, vol. 7, no. 24, pp. 10790–10800, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Sánchez, P. Mendoza, H. R. Contreras et al., “Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs,” The Prostate, vol. 69, no. 13, pp. 1448–1459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Xu, M. C. Farach-Carson, and X. Jia, “Three-dimensional in vitro tumor models for cancer research and drug evaluation,” Biotechnology Advances, vol. 32, no. 7, pp. 1256–1268, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Håkanson, M. Textor, and M. Charnley, “Engineered 3D environments to elucidate the effect of environmental parameters on drug response in cancer,” Integrative Biology, vol. 3, no. 1, pp. 31–38, 2011. View at Publisher · View at Google Scholar
  43. C. Fischbach, R. Chen, T. Matsumoto et al., “Engineering tumors with 3D scaffolds,” Nature Methods, vol. 4, no. 10, pp. 855–860, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Kocatürk and H. H. Versteeg, “Orthotopic injection of breast cancer cells into the mammary fat pad of mice to study tumor growth,” Journal of Visualized Experiments, no. 96, Article ID e51967, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Iorns, K. Drews-Elger, T. M. Ward et al., “A new mouse model for the study of human breast cancer metastasis,” PLoS ONE, vol. 7, no. 10, Article ID e47995, 2012. View at Publisher · View at Google Scholar · View at Scopus